Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Neoplasms of the CNS

  Free Subscription


Articles published in J Neuropathol Exp Neurol

Retrieve available abstracts of 107 articles:
HTML format



Single Articles


    July 2022
  1. MO H, Magaki S, Deisch JK, Raghavan R, et al
    Isocitrate Dehydrogenase Mutations Are Associated with Different Expression and DNA Methylation Patterns of OLIG2 in Adult Gliomas.
    J Neuropathol Exp Neurol. 2022 Jul 20. pii: 6647005. doi: 10.1093.
    PubMed     Abstract available


  2. LUCAS CG, Davidson CJ, Alashari M, Putnam AR, et al
    Targeted Next-Generation Sequencing Reveals Divergent Clonal Evolution in Components of Composite Pleomorphic Xanthoastrocytoma-Ganglioglioma.
    J Neuropathol Exp Neurol. 2022;81:650-657.
    PubMed     Abstract available


    June 2022

  3. Correction to: Tumor-Derived Cell Culture Model for the Investigation of Meningioma Biology.
    J Neuropathol Exp Neurol. 2022 Jun 17. pii: 6613581. doi: 10.1093.
    PubMed    


    May 2022
  4. LIU C, Chen X, Zhang L, Liu J, et al
    F-Box Protein 11 Suppresses Cell Proliferation and Aerobic Glycolysis in Glioblastomas by Mediating the Ubiquitin Degradation of Cdc25A.
    J Neuropathol Exp Neurol. 2022 May 18. pii: 6587358. doi: 10.1093.
    PubMed     Abstract available


  5. TUNA G, Dal-Bekar NE, Akay A, Ruksen M, et al
    Minimally Invasive Detection of IDH1 Mutation With Cell-Free Circulating Tumor DNA and D-2-Hydroxyglutarate, D/L-2-Hydroxyglutarate Ratio in Gliomas.
    J Neuropathol Exp Neurol. 2022 May 18. pii: 6587360. doi: 10.1093.
    PubMed     Abstract available


    April 2022
  6. PASCUAL JM, Prieto R, Carrasco R, Barrios L, et al
    Basal Recess in Third Ventricle Tumors: A Pathological Feature Defining a Clinical-Topographical Subpopulation of Papillary Craniopharyngiomas.
    J Neuropathol Exp Neurol. 2022 Apr 26. pii: 6574454. doi: 10.1093.
    PubMed     Abstract available


  7. SAHU U, Barth RF, Otani Y, McCormack R, et al
    Rat and Mouse Brain Tumor Models for Experimental Neuro-Oncology Research.
    J Neuropathol Exp Neurol. 2022 Apr 21. pii: 6572007. doi: 10.1093.
    PubMed     Abstract available


    March 2022
  8. TROY C, Gill BJA, Miller ML, Hickman RA, et al
    Adenocarcinoma Arising in a Yolk Sac Tumor of the Pineal Gland.
    J Neuropathol Exp Neurol. 2022;81:291-295.
    PubMed    


  9. VALERIO E, Alves de Castro JV, Carraro DM, Torrezan GT, et al
    Beyond Midline: Diffuse Hemispheric Glioma, H3 K27M-Mutant with Aggressive Behavior.
    J Neuropathol Exp Neurol. 2022 Mar 18. pii: 6550548. doi: 10.1093.
    PubMed    


    February 2022
  10. TOGNI C, Rom E, Burghardt I, Roth P, et al
    Prognostic Relevance of Transforming Growth Factor-beta Receptor Expression and Signaling in Glioblastoma, Isocitrate Dehydrogenase-Wildtype.
    J Neuropathol Exp Neurol. 2022;81:225-235.
    PubMed     Abstract available


    January 2022
  11. BITAR M, Chornenkyy Y, Flanagan ME, Steffens A, et al
    The Frequency of Focal Cortical Dysplasia-Like Histologic Features Near Adult-Type Diffuse Gliomas.
    J Neuropathol Exp Neurol. 2022;81:48-53.
    PubMed     Abstract available


  12. ABOUBAKR O, Metais A, Berthaud C, Gigant P, et al
    L1CAM Is Not a Reliable Diagnostic Biomarker for Distinguishing Supratentorial Ependymomas, ZFTA Fusion-Positive From Other Central Nervous System Tumors.
    J Neuropathol Exp Neurol. 2022;81:82-85.
    PubMed    


  13. ONYENEKWU CP, Cunningham AM, Schilter K, Reddi HV, et al
    Diffuse Leptomeningeal Histiocytic Sarcoma: Histologic and Molecular Findings in an Autopsy Case.
    J Neuropathol Exp Neurol. 2022;81:79-81.
    PubMed    


  14. VIZCAINO MA, Kurtin PJ, King RL, Spinner RJ, et al
    Diffuse Large B-Cell Lymphoma of Peripheral Nerve with Distinctive Pathological Features Resembling Primary CNS Lymphoma.
    J Neuropathol Exp Neurol. 2022;81:76-78.
    PubMed    


    December 2021
  15. KRONISH A, DeNardo B, Kanach C, Lulla RR, et al
    Activating BRAF G469A Missense Mutation in a Pediatric Patient With High-Grade Glioma.
    J Neuropathol Exp Neurol. 2021;80:1141-1142.
    PubMed    


  16. KIMURA T, Ikedo T, Ohta-Ogo K, Hamano E, et al
    A Pathologically Verified Case of Peripheral Intracranial Aneurysmal Formation With Massively Infiltrating Meningioma Cells.
    J Neuropathol Exp Neurol. 2021 Dec 29. pii: 6487232. doi: 10.1093.
    PubMed    


  17. SASAKI S, Takeda M, Hirose T, Fujii T, et al
    Correlation of MTAP Immunohistochemistry With CDKN2A Status Assessed by Fluorescence In Situ Hybridization and Clinicopathological Features in CNS WHO Grade 2 and 3 Meningiomas: A Single Center Cohort Study.
    J Neuropathol Exp Neurol. 2021 Dec 13. pii: 6460154. doi: 10.1093.
    PubMed     Abstract available


  18. ROSAGER AM, Dahlrot RH, Sorensen MD, Bangso JA, et al
    The Epigenetic Regulator Jumonji Domain-Containing Protein 6 (JMJD6) Is Highly Expressed but Not Prognostic in IDH-Wildtype Glioblastoma Patients.
    J Neuropathol Exp Neurol. 2021 Dec 7. pii: 6454863. doi: 10.1093.
    PubMed     Abstract available


  19. LARKIN CJ, Jennings LJ, Heimberger AB, Horbinski C, et al
    Next-Generation Sequencing of a Glioblastoma with True Epithelial Differentiation.
    J Neuropathol Exp Neurol. 2021 Dec 3. pii: 6448594. doi: 10.1093.
    PubMed    


    November 2021
  20. UHLMANN EJ, Rabinovsky R, Varma H, El Fatimy R, et al
    Tumor-Derived Cell Culture Model for the Investigation of Meningioma Biology.
    J Neuropathol Exp Neurol. 2021 Nov 28. pii: 6445140. doi: 10.1093.
    PubMed     Abstract available


  21. LIND KT, Chatwin HV, DeSisto J, Coleman P, et al
    Novel RAF Fusions in Pediatric Low-Grade Gliomas Demonstrate MAPK Pathway Activation.
    J Neuropathol Exp Neurol. 2021 Nov 28. pii: 6445141. doi: 10.1093.
    PubMed     Abstract available


  22. CHKHEIDZE R, Raisanen J, Gagan J, Richardson TE, et al
    Alterations in the RB Pathway With Inactivation of RB1 Characterize Glioblastomas With a Primitive Neuronal Component.
    J Neuropathol Exp Neurol. 2021 Nov 28. pii: 6445139. doi: 10.1093.
    PubMed     Abstract available


  23. KLEINSCHMIDT-DEMASTERS BK
    Metastases to the Pituitary Gland: Histological Patterns of Spread and Review of the Literature.
    J Neuropathol Exp Neurol. 2021;80:1033-1042.
    PubMed     Abstract available


    October 2021
  24. OON ML, Low SYY, Kuick CH, Goh JY, et al
    An Unusual Ganglioglioma with Pseudopapillary Features and PRKAR2B-BRAF Fusion.
    J Neuropathol Exp Neurol. 2021;80:1000-1003.
    PubMed    


  25. LIN CC, Mansukhani MM, Bruce JN, Canoll P, et al
    Rosette-Forming Glioneuronal Tumor in the Pineal Region: A Series of 6 Cases and Literature Review.
    J Neuropathol Exp Neurol. 2021;80:933-943.
    PubMed     Abstract available


  26. AHN JS, Ervin J, Cummings TJ, Lopez GY, et al
    Papillary Glioneuronal Tumor With a Novel GPR37L1-PRKCA Fusion.
    J Neuropathol Exp Neurol. 2021;80:1004-1006.
    PubMed    


    September 2021
  27. AHRENDSEN JT, Sinai C, Meredith DM, Malinowski SW, et al
    Molecular Alterations in Pediatric Low-Grade Gliomas That Led to Death.
    J Neuropathol Exp Neurol. 2021 Sep 27. pii: 6377085. doi: 10.1093.
    PubMed     Abstract available


  28. KARPATHIOU G, Ferrand E, Camy F, Babiuc SM, et al
    Expression of STAT6 and Phosphorylated STAT6 in Primary Central Nervous System Lymphomas.
    J Neuropathol Exp Neurol. 2021;80:830-834.
    PubMed     Abstract available


  29. LIN CC, Lefferts JA, Chan AM, Zanazzi G, et al
    Rare Activating BRAF Alteration Involving the beta3-alphaC Kinase Domain in Ganglioglioma.
    J Neuropathol Exp Neurol. 2021;80:887-889.
    PubMed    


  30. DONO A, Pothiawala AZ, Lewis CT, Bhattacharjee MB, et al
    Molecular Alterations in Meningioangiomatosis Causing Epilepsy.
    J Neuropathol Exp Neurol. 2021 Sep 27. pii: 6377086. doi: 10.1093.
    PubMed     Abstract available


  31. SMITH HL, Collins J, Park D, Darlington W, et al
    Pediatric Gliomas Presenting with Gliomatosis-Like Spread, Lack of Contrast Enhancement, EGFR Mutation, and TERT Promoter Variants.
    J Neuropathol Exp Neurol. 2021 Sep 15. pii: 6370674. doi: 10.1093.
    PubMed    


  32. CHEN J, Lee H, Schmitt P, Choy CJ, et al
    Bioengineered Models to Study Microenvironmental Regulation of Glioblastoma Metabolism.
    J Neuropathol Exp Neurol. 2021 Sep 15. pii: 6370675. doi: 10.1093.
    PubMed     Abstract available


  33. SUGITA Y, Hashimoto G, Fukuda K, Takahashi K, et al
    Primary Nondural Central Nervous System Marginal ZoneB-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type Mimicking CNS Inflammatory Diseases.
    J Neuropathol Exp Neurol. 2021;80:789-799.
    PubMed     Abstract available


  34. AHANGARI N, Munoz DG, Coulombe J, Gray DA, et al
    Nuclear IMPDH Filaments in Human Gliomas.
    J Neuropathol Exp Neurol. 2021 Sep 8. pii: 6366485. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  35. MOVAHED-EZAZI M, Skalina KA, Parashar K, Manjila S, et al
    A Rare Presentation of Low-Grade Prostate Adenocarcinoma as Delayed Pineal Region Metastasis: A Case Report and Review of Multicenter Clinical Experience in Prostate Carcinoma Brain Metastases.
    J Neuropathol Exp Neurol. 2021 Aug 13. pii: 6350804. doi: 10.1093.
    PubMed    


  36. LEBRUN L, Bizet M, Melendez B, Alexiou B, et al
    Analyses of DNA Methylation Profiling in the Diagnosis of Intramedullary Astrocytomas.
    J Neuropathol Exp Neurol. 2021;80:663-673.
    PubMed     Abstract available


  37. COVELLI C, Parente P, Icolaro N, Dimitri LMC, et al
    Primary Epithelioid Hemangioma of the Central Nervous System: A Case Report and Review of the Literature.
    J Neuropathol Exp Neurol. 2021;80:717-719.
    PubMed    


    July 2021
  38. FOIANI G, Guelfi G, Mandara MT
    MicroRNA Dysregulation in Canine Meningioma: RT-qPCR Analysis of Formalin-Fixed Paraffin-Embedded Samples.
    J Neuropathol Exp Neurol. 2021 Jul 17. pii: 6323287. doi: 10.1093.
    PubMed     Abstract available


  39. PROSNIAK M, Kenyon LC, Hooper DC
    Glioblastoma Contains Topologically Distinct Proliferative and Metabolically Defined Subpopulations of Nestin- and Glut1-Expressing Cells.
    J Neuropathol Exp Neurol. 2021 Jul 16. pii: 6322918. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  40. LUCAS CG, Devine P, Solomon DA, Giannini C, et al
    Sarcomatous Meningioma: Diagnostic Pitfalls and the Utility of Molecular Testing.
    J Neuropathol Exp Neurol. 2021 Jun 12. pii: 6297520. doi: 10.1093.
    PubMed     Abstract available


    May 2021
  41. KNUDSEN AM, Rudkjobing SJ, Sorensen MD, Dahlrot RH, et al
    Expression and Prognostic Value of the Immune Checkpoints Galectin-9 and PD-L1 in Glioblastomas.
    J Neuropathol Exp Neurol. 2021 May 15. pii: 6276054. doi: 10.1093.
    PubMed     Abstract available


  42. HIRAKI T, Fukuoka K, Mori M, Arakawa Y, et al
    Application of Genome-Wide DNA Methylation Analysis to Differentiate a Case of Radiation-Induced Glioblastoma From Late-Relapsed Medulloblastoma.
    J Neuropathol Exp Neurol. 2021 May 15. pii: 6276056. doi: 10.1093.
    PubMed     Abstract available


    April 2021
  43. GOSCHZIK T, Zur Muehlen A, Doerner E, Waha A, et al
    Medulloblastoma in Adults: Cytogenetic Phenotypes Identify Prognostic Subgroups.
    J Neuropathol Exp Neurol. 2021;80:419-430.
    PubMed     Abstract available


  44. STEPHEN NIX J, Ida CM
    What Every Neuropathologist Needs to Know: Practical Aspects and Pitfalls in Molecular Diagnosis of Brain Tumors.
    J Neuropathol Exp Neurol. 2021 Apr 9. pii: 6219399. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  45. DAHL NA, Donson AM, Sanford B, Wang D, et al
    NTRK Fusions Can Co-Occur With H3K27M Mutations and May Define Druggable Subclones Within Diffuse Midline Gliomas.
    J Neuropathol Exp Neurol. 2021 Mar 22. pii: 6179633. doi: 10.1093.
    PubMed     Abstract available


  46. RICHARDSON TE, Sathe AA, Xing C, Mirchia K, et al
    Molecular Signatures of Chromosomal Instability Correlate With Copy Number Variation Patterns and Patient Outcome in IDH-Mutant and IDH-Wildtype Astrocytomas.
    J Neuropathol Exp Neurol. 2021;80:354-365.
    PubMed     Abstract available


  47. ULLOA-NAVAS MJ, Rubio L, Teruel-Sanchis A, Pena-Pena J, et al
    Heterogeneous Pattern of Differentiation With BCAS1/NABC1 Expression in a Case of Oligodendroglioma.
    J Neuropathol Exp Neurol. 2021;80:379-383.
    PubMed    


  48. PHAM K, Maxwell MJ, Sweeney H, Alt J, et al
    Novel Glutamine Antagonist JHU395 Suppresses MYC-Driven Medulloblastoma Growth and Induces Apoptosis.
    J Neuropathol Exp Neurol. 2021 Mar 13. pii: 6169464. doi: 10.1093.
    PubMed     Abstract available


    February 2021
  49. SMITH MJ, Pathmanaban ON, Coope DJ, King AT, et al
    Comment on: SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM.
    J Neuropathol Exp Neurol. 2021;80:289-290.
    PubMed    


  50. FONKEM E, Peng S, Berens M, Mukherjee S, et al
    Authors' Reply: SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM.
    J Neuropathol Exp Neurol. 2021;80:290-291.
    PubMed    


  51. MIYAKE Y, Fujii K, Nakamaura T, Ikegaya N, et al
    IDH-Mutant Astrocytoma With Chromosome 19q13 Deletion Manifesting as an Oligodendroglioma-Like Morphology.
    J Neuropathol Exp Neurol. 2021;80:247-253.
    PubMed     Abstract available


  52. DAOUD EV, Patel A, Gagan J, Raisanen JM, et al
    Spinal Cord Pilocytic Astrocytoma With FGFR1-TACC1 Fusion and Anaplastic Transformation.
    J Neuropathol Exp Neurol. 2021;80:283-285.
    PubMed    


  53. PRYZBYLSKI AL, Kollmeyer TM, Praska CE, Raghunathan A, et al
    Non-canonical IDH Mutation Frequency in IDH1-R132H-Negative Glioblastoma Patients Older Than 54 Years.
    J Neuropathol Exp Neurol. 2021 Feb 7. pii: 6130116. doi: 10.1093.
    PubMed    


  54. HEALY E
    Corrigendum to: SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM.
    J Neuropathol Exp Neurol. 2021 Feb 4. pii: 6127560. doi: 10.1093.
    PubMed    


    January 2021
  55. MOVAHED-EZAZI M, Schwartz PJ, Zimmerman DL, Song X, et al
    Subependymal Giant Cell Astrocytoma in a 79-Year-Old Woman without Clinical Features of Tuberous Sclerosis: A Case Report.
    J Neuropathol Exp Neurol. 2021;80:199-201.
    PubMed    


  56. YEUNG J, Yaghoobi V, Aung TN, Vesely MD, et al
    Spatially Resolved and Quantitative Analysis of the Immunological Landscape in Human Meningiomas.
    J Neuropathol Exp Neurol. 2021 Jan 4. pii: 6061497. doi: 10.1093.
    PubMed     Abstract available


  57. HOLSTEN T, Lubieniecki F, Spohn M, Mynarek M, et al
    Detailed Clinical and Histopathological Description of 8 Cases of Molecularly Defined CNS Neuroblastomas.
    J Neuropathol Exp Neurol. 2021;80:52-59.
    PubMed     Abstract available


  58. BARRESI V, Simbolo M, Gessi M, Rossi S, et al
    Clinical-Pathological, Immunohistochemical, and Genetic Characterization of a Series of Posterior Pituitary Tumors.
    J Neuropathol Exp Neurol. 2021;80:45-51.
    PubMed     Abstract available


  59. ARCHILLA I, Guerrero J, Reyes Figueroa LA, Capurro S, et al
    Intra-Axial Frontal Cyst with Ependymoma-Like Proliferation: Neuroectodermal or Neurenteric?
    J Neuropathol Exp Neurol. 2021;80:93-95.
    PubMed    


    December 2020
  60. WANG YH, Huang TL, Chen X, Yu SX, et al
    Glioma-Derived TSP2 Promotes Excitatory Synapse Formation and Results in Hyperexcitability in the Peritumoral Cortex of Glioma.
    J Neuropathol Exp Neurol. 2020 Dec 31. pii: 6056628. doi: 10.1093.
    PubMed     Abstract available


  61. MITANI Y, Fukuoka K, Mori M, Arakawa Y, et al
    Clinical Aggressiveness of TP53-Wild Type Sonic Hedgehog Medulloblastoma With MYCN Amplification, Chromosome 17p Loss, and Chromothripsis.
    J Neuropathol Exp Neurol. 2020 Dec 25. pii: 6047589. doi: 10.1093.
    PubMed    


  62. GOODMAN AL, Velazquez Vega JE, Rey Martinez LC, Brat DJ, et al
    Epithelioid Pituicytoma: Expanding the Morphologic Spectrum of a Rare Neoplasm.
    J Neuropathol Exp Neurol. 2020;79:1376-1378.
    PubMed    


    November 2020
  63. NATSUMEDA M, Miyahara H, Yoshimura J, Nakata S, et al
    GLI3 Is Associated With Neuronal Differentiation in SHH-Activated and WNT-Activated Medulloblastoma.
    J Neuropathol Exp Neurol. 2020 Nov 29. pii: 6010620. doi: 10.1093.
    PubMed     Abstract available


  64. ALSAFWANI N, Alrjoub M, Djuric U, Gao A, et al
    Tumor-Infiltrating Lymphocytes Are Enriched in Nonhypoxic Glioblastoma Niches.
    J Neuropathol Exp Neurol. 2020 Nov 19. pii: 5992386. doi: 10.1093.
    PubMed    


  65. YAO K, Duan Z, Du Z, Fan X, et al
    PRKCA D463H Mutation in Chordoid Glioma of the Third Ventricle: A Cohort of 16 Cases, Including Two Cases Harboring BRAFV600E Mutation.
    J Neuropathol Exp Neurol. 2020;79:1183-1192.
    PubMed     Abstract available


  66. NAVALKELE P, Guzman M, Kirby A, Pinz H, et al
    Familial Pediatric Clear Cell Meningioma With Germline SMARCE1 Mutation in the United States.
    J Neuropathol Exp Neurol. 2020;79:1250-1252.
    PubMed    


  67. GILBERT AR, Yan L, McDougall CM
    Broadening the Age of Incidence of Intracranial Angiomatoid Fibrous Histiocytoma With EWSR1-CREM Fusion: A Case Report.
    J Neuropathol Exp Neurol. 2020;79:1244-1246.
    PubMed    


  68. SAN-MIGUEL T, Navarro L, Sanchez-Sendra B, Megias J, et al
    Identification of a Novel BRCA1 Alteration in Recurrent Melanocytoma Resulting in Increased Proliferation.
    J Neuropathol Exp Neurol. 2020;79:1233-1238.
    PubMed     Abstract available


  69. ZHENG H, Baranova K, Song J, Yan L, et al
    Overexpression of Long Noncoding RNA HOTAIR Is a Unique Epigenetic Characteristic of Myxopapillary Ependymoma.
    J Neuropathol Exp Neurol. 2020;79:1193-1202.
    PubMed     Abstract available


    October 2020
  70. SALLE H, Durand K, Gantois C, Labrousse F, et al
    Myxoid Meningioma: First Report of a Rare Metaplastic Meningioma Variant in the Pineal Region.
    J Neuropathol Exp Neurol. 2020 Oct 17. pii: 5928920. doi: 10.1093.
    PubMed    


  71. RICHARDSON TE, Kumar A, Xing C, Hatanpaa KJ, et al
    Overcoming the Odds: Toward a Molecular Profile of Long-Term Survival in Glioblastoma.
    J Neuropathol Exp Neurol. 2020;79:1031-1037.
    PubMed     Abstract available


  72. MORRIS M, Driscoll M, Henson JW, Cobbs C, et al
    Low-Grade Gemistocytic Morphology in H3 G34R-Mutant Gliomas and Concurrent K27M Mutation: Clinicopathologic Findings.
    J Neuropathol Exp Neurol. 2020;79:1038-1043.
    PubMed     Abstract available


  73. GITTO L, Serinelli S, Galbraith K, Williams M, et al
    Anaplastic Transformation in Myxopapillary Ependymoma: A Report of 2 Cases and Review of the Literature.
    J Neuropathol Exp Neurol. 2020;79:1044-1053.
    PubMed     Abstract available


    September 2020
  74. DAL COL P, Poncet D, Rivoirard R, Vassal F, et al
    Acquired ATRX Loss and ALT Phenotype Through Tumor Recurrences in a Case of Pleomorphic Xanthoastrocytoma Suggest Their Possible Roles in Tumor Progression.
    J Neuropathol Exp Neurol. 2020;79:1011-1014.
    PubMed     Abstract available


    August 2020
  75. PETTERSON SA, Sorensen MD, Kristensen BW
    Expression Profiling of Primary and Recurrent Glioblastomas Reveals a Reduced Level of Pentraxin 3 in Recurrent Glioblastomas.
    J Neuropathol Exp Neurol. 2020 Aug 13. pii: 5892401. doi: 10.1093.
    PubMed     Abstract available


  76. QI S, Liu Y, Wang C, Fan J, et al
    Membrane Structures Between Craniopharyngioma and the Third Ventricle Floor Based on the QST Classification and Its Significance: A Pathological Study.
    J Neuropathol Exp Neurol. 2020 Aug 13. pii: 5892406. doi: 10.1093.
    PubMed     Abstract available


  77. TANG K, Gardner S, Snuderl M
    The Role of Liquid Biopsies in Pediatric Brain Tumors.
    J Neuropathol Exp Neurol. 2020 Aug 7. pii: 5882050. doi: 10.1093.
    PubMed     Abstract available


  78. MIKKELSEN VE, Dai HY, Stensjoen AL, Berntsen EM, et al
    MGMT Promoter Methylation Status Is Not Related to Histological or Radiological Features in IDH Wild-type Glioblastomas.
    J Neuropathol Exp Neurol. 2020;79:855-862.
    PubMed     Abstract available


  79. ZANAZZI G, Pendrick D, Lin CC, Higgins D, et al
    Pineal Region High-Grade Glioneuronal Tumor With a Novel ZBTB10-NTRK3 Fusion.
    J Neuropathol Exp Neurol. 2020;79:929-931.
    PubMed    


  80. TANG K, Kurland D, Vasudevaraja V, Serrano J, et al
    Exploring DNA Methylation for Prognosis and Analyzing the Tumor Microenvironment in Pleomorphic Xanthoastrocytoma.
    J Neuropathol Exp Neurol. 2020;79:880-890.
    PubMed     Abstract available


    July 2020
  81. FURUTA T, Sugita Y, Komaki S, Ohshima K, et al
    The Multipotential of Leucine-Rich alpha-2 Glycoprotein 1 as a Clinicopathological Biomarker of Glioblastoma.
    J Neuropathol Exp Neurol. 2020 Jul 10. pii: 5869580. doi: 10.1093.
    PubMed     Abstract available


  82. GALBRAITH K, Kumar A, Abdullah KG, Walker JM, et al
    Molecular Correlates of Long Survival in IDH-Wildtype Glioblastoma Cohorts.
    J Neuropathol Exp Neurol. 2020 Jul 10. pii: 5869581. doi: 10.1093.
    PubMed     Abstract available


  83. HUIZER K, Zhu C, Chirifi I, Krist B, et al
    Periostin Is Expressed by Pericytes and Is Crucial for Angiogenesis in Glioma.
    J Neuropathol Exp Neurol. 2020 Jul 10. pii: 5869578. doi: 10.1093.
    PubMed     Abstract available


  84. MORISAKO T, Shishido-Hara Y, Inaba T, Takeuchi H, et al
    Primary CNS CD45-Depleted T-Cell Lymphoma: The First Pathologically Confirmed Case.
    J Neuropathol Exp Neurol. 2020;79:817-820.
    PubMed    


  85. SHAHAB S, Rubens J, Kaur H, Sweeney H, et al
    MEK Inhibition Suppresses Growth of Atypical Teratoid/Rhabdoid Tumors.
    J Neuropathol Exp Neurol. 2020;79:746-753.
    PubMed     Abstract available


    June 2020
  86. KAM KL, Appin CL, Mao Q, Ikegami S, et al
    Is Next-Generation Sequencing Alone Sufficient to Reliably Diagnose Gliomas?
    J Neuropathol Exp Neurol. 2020 Jun 1. pii: 5850092. doi: 10.1093.
    PubMed     Abstract available


    May 2020
  87. GAUCHOTTE G, Peyre M, Pouget C, Cazals-Hatem D, et al
    Prognostic Value of Histopathological Features and Loss of H3K27me3 Immunolabeling in Anaplastic Meningioma: A Multicenter Retrospective Study.
    J Neuropathol Exp Neurol. 2020 May 24. pii: 5843545. doi: 10.1093.
    PubMed     Abstract available


  88. ZHU LY, Wu XY, Liu XD, Zheng DF, et al
    Aggressive Medulloblastoma-Derived Exosomal miRNAs Promote In Vitro Invasion and Migration of Tumor Cells Via Ras/MAPK Pathway.
    J Neuropathol Exp Neurol. 2020 May 17. pii: 5838430. doi: 10.1093.
    PubMed     Abstract available


  89. MUKHERJEE S, Stroberg E, Wang F, Morales L, et al
    SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM.
    J Neuropathol Exp Neurol. 2020;79:562-565.
    PubMed     Abstract available


  90. AHRENDSEN JT, Hsu N, Wolf Z, Bryke C, et al
    Multiple Whole Chromosomal Gains Define Angiomatous Meningiomas and Are Absent From the Tumor Vasculature.
    J Neuropathol Exp Neurol. 2020 May 1. pii: 5827861. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  91. FIORAVANZO A, Caffo M, Di Bonaventura R, Gardiman MP, et al
    A Risk Score Based on 5 Clinico-Pathological Variables Predicts Recurrence of Atypical Meningiomas.
    J Neuropathol Exp Neurol. 2020 Mar 31. pii: 5814172. doi: 10.1093.
    PubMed     Abstract available


  92. NAKATA S, Price A, Eberhart C, Morris M, et al
    Increased Tau Expression Correlates With IDH Mutation in Infiltrating Gliomas and Impairs Cell Migration.
    J Neuropathol Exp Neurol. 2020 Mar 17. pii: 5809104. doi: 10.1093.
    PubMed     Abstract available


  93. BALLESTER LY, Meis JM, Lazar AJ, Prabhu SS, et al
    Intracranial Myxoid Mesenchymal Tumor With EWSR1-ATF1 Fusion.
    J Neuropathol Exp Neurol. 2020;79:347-351.
    PubMed     Abstract available


  94. SALLE H, Pocard M, Lehmann-Che J, Bourthoumieu S, et al
    Development of a Novel Orthotopic Primary Human Chordoma Xenograft Model: A Relevant Support for Future Research on Chordoma.
    J Neuropathol Exp Neurol. 2020;79:314-324.
    PubMed     Abstract available


    February 2020
  95. BODOR C, Alpar D, Marosvari D, Galik B, et al
    Molecular Subtypes and Genomic Profile of Primary Central Nervous System Lymphoma.
    J Neuropathol Exp Neurol. 2020;79:176-183.
    PubMed     Abstract available


    January 2020
  96. D'ARCY CE, Nobre LF, Arnaldo A, Ramaswamy V, et al
    Immunohistochemical and nanoString-Based Subgrouping of Clinical Medulloblastoma Samples.
    J Neuropathol Exp Neurol. 2020 Jan 30. pii: 5735424. doi: 10.1093.
    PubMed     Abstract available


  97. HEWER E, Phour J, Gutt-Will M, Schucht P, et al
    TERT Promoter Mutation Analysis to Distinguish Glioma From Gliosis.
    J Neuropathol Exp Neurol. 2020 Jan 29. pii: 5740035. doi: 10.1093.
    PubMed     Abstract available


  98. HO CY, Bornhorst M, Almira-Suarez MI, Donev K, et al
    Clinicopathologic Features of Diencephalic Neuronal and Glioneuronal Tumors.
    J Neuropathol Exp Neurol. 2020;79:67-73.
    PubMed     Abstract available


  99. KLEINSCHMIDT-DEMASTERS BK
    Pituitary Adenomas in Transgender Individuals?
    J Neuropathol Exp Neurol. 2020;79:62-66.
    PubMed     Abstract available


    December 2019
  100. MARTIN AM, Bell WR, Yuan M, Harris L, et al
    PD-L1 Expression in Pediatric Low-Grade Gliomas Is Independent of BRAF V600E Mutational Status.
    J Neuropathol Exp Neurol. 2019 Dec 9. pii: 5670883. doi: 10.1093.
    PubMed     Abstract available


    November 2019
  101. PI CASTRO D, Jose-Lopez R, Fernandez Flores F, Rabanal Prados RM, et al
    Expression of FOXP3 in Canine Gliomas: Immunohistochemical Study of Tumor-Infiltrating Regulatory Lymphocytes.
    J Neuropathol Exp Neurol. 2019 Nov 11. pii: 5679984. doi: 10.1093.
    PubMed     Abstract available


    September 2019
  102. RICHARDSON TE, Tang K, Vasudevaraja V, Serrano J, et al
    GOPC-ROS1 Fusion Due to Microdeletion at 6q22 Is an Oncogenic Driver in a Subset of Pediatric Gliomas and Glioneuronal Tumors.
    J Neuropathol Exp Neurol. 2019 Sep 16. pii: 5593615. doi: 10.1093.
    PubMed     Abstract available


  103. CHKHEIDZE R, Cimino PJ, Hatanpaa KJ, White CL, et al
    Distinct Expression Patterns of Carbonic Anhydrase IX in Clear Cell, Microcystic, and Angiomatous Meningiomas.
    J Neuropathol Exp Neurol. 2019 Sep 12. pii: 5582700. doi: 10.1093.
    PubMed     Abstract available


    February 2019
  104. XU C, Mao L, Xiong J, Wen J, et al
    TAZ Expression on Endothelial Cells Is Closely Related to Blood Vascular Density and VEGFR2 Expression in Astrocytomas.
    J Neuropathol Exp Neurol. 2019;78:172-180.
    PubMed     Abstract available


  105. AHN JS, Harrison W, Hughes E, McLendon RE, et al
    Intraventricular Pilocytic Astrocytoma With KIAA1549/BRAF Fusion Arising in a 44-Year Old.
    J Neuropathol Exp Neurol. 2019;78:187-190.
    PubMed     Abstract available


    January 2019
  106. DAOUD EV, Wachsmann M, Richardson TE, Mella D, et al
    Spinal Pleomorphic Xanthoastrocytoma With a QKI-RAF1 Fusion.
    J Neuropathol Exp Neurol. 2019;78:10-14.
    PubMed     Abstract available


  107. LIPP ES, Healy P, Austin A, Clark A, et al
    MGMT: Immunohistochemical Detection in High-Grade Astrocytomas.
    J Neuropathol Exp Neurol. 2019;78:57-64.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: